Psychoneuroimmunological pathways and sex differences in coronary artery disease: The role of inflammation and estrogen

Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives

Volumn , Issue , 2015, Pages 129-149

  Kop, Willem J ^a   Mommersteeg, Paula M C ^a  

^a TILBURG UNIVERSITY   (Netherlands)

Author keywords

Coronary Artery Disease; Depression; Estrogen; Inflammation; Myocardial ischemia; Psychological stress; Sex; Women S Health

Indexed keywords

EID: 84943626693     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-09241-6_9     Document Type: Chapter

References (103)

1. Adams, D. O. (1994). Molecular biology of macrophage activation: A pathway whereby psychosocial factors can potentially affect health. Psychosomatic Medicine, 56(A), 316-327.
2. Appels A, Bar. F W, Bar J Bruggeman C, & de Baets, M. (2000). Inflammation, depressive symptomtology, and coronary artery disease. Psychosomatic Medicine, 62(5), 601-605.
3. Arbab-Zadeh, A., Nakano, M., Virmani, R., & Fuster, V. (2012). Acute coronary events. Circulation, 125(9), 1147-1156. doi:10.1161/CIRCULATIONAHA.111.047431.
4. Arsenault B, Cartier A, Cote M, Lemieux I, Tremblay A, Bouchard C, Despres JP. (2009). Body composition, cardiorespiratory fitness, and low-grade inflammation in middleaged men and women. American Journal of Cardiology, 104(2), 240-246. doi:10.1016/j.amjcard.2009.03.027.
5. Arthur HM, Campbell P, Harvey PJ, McGillion M, Oh P, Woodburn E, Hodgson C. (2012). Women, cardiac syndrome X. and microvascular heart disease. The Canadian Journal of Cardiology, 28(2 Suppliment), S42-S49. doi: 10.1016/j.cjca.2011.09.006.
6. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M. WISE Investigators. (2006). Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. Journal of the American College of Cardiology, 47(3 Suppliment). S21-S29. doi: 10.1016/j.jacc.2004.12.084.
7. Black P. H. (2003). The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain, Behavior, and Immunity, 17(5), 350-364. P2: S0889159103000485.
8. Bromberger JT, Schott LL, Kravitz HM, Sowers M, Avis NE, Gold EB, Karen AM. (2010). Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: Results from the Study of Women’s Health Across the Nation (SWAN). Archives of General Psychiatiy, 67(6), 598-607. doi:10.1001/archgenpsychiatry. 2010.55.
9. CBS. (2013a). Doodsoorzaken [Causes of death], CBS Statline. Retrieved September 1. 2013, from http://statline.cbs.nl/
10. CBS. (2013b). Tweedelijns curatieve (geneeskundige) geestelijke gezondheidszorg [Mental health treatment], CBS Statline. Retrieved October 30. 2013, from http://statline.cbs.nl/
11. Chakrabarti, S. & Davidge, S. T. (2012). G-protein coupled receptor 30 (GPR30): A novel regulator of endothelial inflammation. PLoS One, 7(12). e52357. doi:10.1371/journal.pone.0052357.
12. Chiaramonte, G. R. & Friend R. (2006). Medical students’ and residents’ gender bias in the diagnosis. treatment, and interpretation of coronary heart disease symptoms. Health Psychology, 25(3), 255-266. doi:10.1037/0278-6133.25.3.255.
13. Cossette, E, Cloutier, I, Tardif, K, DonPierre, G, & Tanguay, J. F. (2013). Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein. Molecular and Cellular Biochemistry, 575(1-2), 137-147. doi: 10.1007/sl 1010-012-1482-9.
14. Cutolo, M, & Calvia, A. (2007). Sex steroids and immunity. In R. Ader (Ed.), Psychoneuroimmunology (4th ed., Vol. 1, pp. 207-215). London: Elsevier Academic.
15. D’Agostino, R. B, Sr, Vasan, R. S, Pencina, M. J, Wolf, P. A, Cobain, M, Massaro, J. M, Kannel, W. B. (2008). General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation, 117(6), 743-753. doi:10.1161/CIRCULATIONAHA. 107.699579.
16. Danesh, J, Collins, R, & Peto, R. (1997). Chronic infections and coronary heart disease: Is there a link? Lancet, 550(9075), 430-436. doi: 10.1016/SO140-6736(97)03079-1.
17. Danesh, J, Wheeler, J. G, Hirschfield, G. M, Eda, S, Eiriksdottir, G, Rumley A Gudnason V. (2004). C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine, 550(14), 1387-1397. doi: 10.1056/NE JMoa032804.
18. Dantzer, R, Sc Kelley, K. W. (1989). Stress and immunity: An integrated view of relationships between the brain and the immune system. Life Sciences, 44(26), 1995-2008.
19. de Villiers, TJ, Gass, ML, Haines, CJ, Hall, JE, Lobo, RA, Pierroz, DD, Rees M. (2013). Global consensus statement on menopausal hormone therapy. Climacteric, 16(2), 203-204. doi: 10.3109/13697137.2013.771520.
20. Denollet, J, Conraads, V. M., Brutsaert, D. L, De Clerck, L. S, Stevens, W. J, Sc Vrints, C. J. (2003). Cytokines and immune activation in systolic heart failure: The role of Type D personality. Brain, Behavior, and Immunity, 17(4), 304-309.
21. Dimsdale, J. E. (2008). Psychological stress and cardiovascular disease. Journal of the American College of Cardiology, 51(13), 1237-1246. doi: 10.1016/j.jacc.2007.12.024.
22. Doran, B, Zhu, W, Sc Muennig, P. (2013). Gender differences in cardiovascular mortality by C-reactive protein level in the United States: Evidence from the National Health and Nutrition Examination Survey III. American Heart Journal, 166(1), 45-51. doi: 10.1016/j. ahj.2013.03.017.
23. Douma, S. L., Husband, C., O’Donnell, M. E., Barwin, B. N., Sc Woodend, A. K. (2005). Estrogenrelated mood disorders: Reproductive life cycle factors. Advances in Nursing Science, 28(A), 364-375. pii: 00012272-200510000-00008.
24. Dubey, R. K., Oparil, S., Imthurn, B., Sc Jackson, E. K. (2002). Sex hormones and hypertension. Cardiovascular Research, 55(3), 688-708. pii: S0008636301005272.
25. Empana, J. P, Sykes, D. H, Luc, G, Juhan-Vague, I, Arveiler, D, Ferrieres, J, PRIME Study Group. (2005). Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 111(18), 2299-2305. doi: 10.1161/01.CIR.0000164203.54111. AE.
26. Fahdi, I. E., Gaddam, V., Garza, L., Romeo, F., & Mehta, J. L. (2003). Inflammation, infection, and atherosclerosis. Brain, Behavior, and Immunity, 17(4), 238-244. pii: S0889159103000527.
27. Fairweather, D., Petri, M. A., Coronado, M. J., Sc Cooper, L. T. (2012). Autoimmune heart disease: Role of sex hormones and autoantibodies in disease pathogenesis. Expert Review of Clinical Immunology, 5(3), 269-284. doi:10.1586/eci.l2.10.
28. Faravelli, C., Alessandra Scarpato, M., Castellini, G., Sc Lo Sauro, C. (2013). Gender differences in depression and anxiety: The role of age. Psychiatry Research, doi: 10.1016/j.psychres.2013.09.027.
29. Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J., & Moeschberger, M. L. (2000). Depression as an antecedent to heart disease among women and men in the NH ANES I study. National Health and Nutrition Examination Survey. Archives of Internal Medicine, 160(9), 1261-1268.
30. Ferrari, A. J., Charlson, F. J., Norman, R. E., Flaxman, A. D., Patten, S. B., Vos, T., Harvey, A. W. (2013a). The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PLoS One, 8(1), e69637. doi:10.1371/joumal.pone. 0069637.
31. Ferrari AJ, Somerville AJ, Baxter AJ, Norman R, Patten SB, Vos T Whiteford HA. (2013b). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471-481. doi: 10.1017/S0033291712001511. Epub 2012 Jul 25.
32. Frasure-Smith, N., & Lesperance, F. (2008). Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Archives of General Psychiatry, 65(1), 62-71.
33. Freeman, E. W., Sammel, M. D., Liu, L., Gracia, C. R., Nelson, D. B., & Hollander, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61(1), 62-70. doi:10.1001/archpsyc.61.1.62.
34. Fricchione GL, Bilfinger TV, Hartman A, Liu Y, & Stefano GB. (1996). Neuroimmunologic implications in coronary artery disease. Advances in Neuroimmunology, 6(2), 131-142.
35. Gameiro, C. M., Romao, F., Sc Castelo-Branco, C. (2010). Menopause and aging: Changes in the immune system-A review. Maturitas, 67(4), 316-320. doi: 10.1016/j.maturitas.2010.08.003.
36. Gibbs, Z., Lee, S., & Kulkarni, J. (2012). What factors determine whether a woman becomes depressed during the perimenopause? Archives of Women’s Mental Health, 15(5), 323-332. doi: 10.1007/s00737-012-0304-0.
37. Gidron, Y., Armon, T., Gilutz, H., Sc Huleihel, M. (2003). Psychological factors correlate meaningfully with percent-monocytes among acute coronary syndrome patients. Brain, Behavior, and Immunity, 17(4), 310-315. pii: S0889159103000618.
38. Go AS, Mozaffarian D, Roger, VL, Benjamin, EJ, Berry, JD, Borden, WB. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2013). Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation, 127(1), e6-e245. doi: 10.1161/CIR.0b013e31828124ad.
39. Gold EB, Crawford SL, Avis NE, Crandall CJ, Matthews KA, Waetjen LE, Harlow SD. (2013). Factors related to age at natural menopause: Longitudinal analyses from SWAN. American Journal of Epidemiology, 178(1), 70-83. doi:10.1093/aje/kws421.
40. Goodkin K, Sc Appels A. (1997). Behavioral-neuroendocrine-immunologic interactions in myocardial infarction. Medical Hypotheses, 48(3), 209-214. pii: S0306-9877(97)90308-X.
41. Hans son, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 552(16), 1685-1695. doi:10.1056/NEJMra043430.
42. Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, Shipley M, Aroon DH. (2010). Evaluating the quality of research into a single prognostic biomarker: A system-atic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Medicine, 7(6), el000286. doi: 10.1371/journal.pmed. 1000286.
43. Herrington, D. M., Sc Howard, T. D. (2003). From presumed benefit to potential harm-hormone therapy and heart disease. The New England Journal of Medicine, 349(6), 519-521. doi: 10.1056/NEJMp038108.
44. Howren MB Lamkin DM, Sc Suls J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71(2), 171-186. doi: 10.1097/PS Y.0b013e3181907clb.
45. Huston, J. M., Sc Tracey, K. J. (2011). The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. Journal of Internal Medicine, 269(1), 45-53. doi:10.1111/j.l365-2796.2010.02321.x.
46. IQWiG. (2013). Wellbeing during menopause. Fact sheet: Menopause Last Update: September 12, 2013. Retrieved November 7, 2013, from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004974/
47. Jespersen L, Hvelplund A, Abildstrom SZ, Pedersen F, Galatius S, Madsen JK, Prescott E. (2012). Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal, 33(6), 734-744. doi:10.1093/eurheartj/ehr331.
48. Kemp, H. G., Jr., Vokonas, P. S., Cohn, P. F., & Gorlin, R. (1973). The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. American Journal of Medicine, 54(6), 735-742.
49. Keyes, K. M., Cheslack-Postava, K., Westhoff, C., Heim, C. M., Haloossim, M., Walsh, K., Karestan, K. (2013). Association of hormonal contraceptive use with reduced levels of depressive symptoms: A national study of sexually active women in the United States. American Journal of Epidemiology, 178(9), 1378-1388. doi:10.1093/aje/kwtl88.
50. Knowlton, A. A., & Lee, A. R. (2012). Estrogen and the cardiovascular system. Pharmacology & Therapeutics, 135(1), 54-70. doi: 10.1016/j.pharmthera.2012.03.007.
51. Kop, W. J., Sc Cohen, N. (2007). Psychoneuroimmunological pathways involved in acute coronary syndromes. In R. Ader (Ed.), Psychoneuroimmunology (4th ed., pp. 921-943). Boston: Academic.
52. Kop, W. J., Sc Gottdiener, J. S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine, 67(Suppliment 1), S37-S41. doi: 10.1097/01.psy.0000162256.18710.4a.
53. Kop WJ, Gottdiener JS, Tangen CM, Fried, LP, McBurnie MA, Walston J, Tracy RP. (2002). Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. The American Journal of Cardiology, 89(4), 419-424. pii: S0002914901022640.
54. Kop, W. J., Stein, P. K., Tracy, R. P., Barzilay, J. I., Schulz, R., Sc Gottdiener, J. S. (2010). Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosomatic Medicine, 72(J), 626-635. doi: 10.1097/PS Y. ObO 13 e3181 eadd2b.
55. Kraus, J. F., Borhani, N. O., Sc Franti, C. E. (1980). Socioeconomic status, ethnicity, and risk of coronary heart disease. American Journal of Epidemiology, 111(4), 407-414.
56. Kresanov P, Ahotupa M, Vasankari T, Kaikkonen J, Kahonen M, Lehtimaki T, Olli TR. (2013). The associations of oxidized high-density lipoprotein lipids with risk factors for atherosclerosis: The Cardiovascular Risk in Young Finns Study. Free Radical Biology & Medicine, 65C, 1284-1290. doi: 10.1016/j.freeradbiomed.2013.09.023.
57. Kuller, L. H., Tracy, R. P., Shaten, J., Sc Meilahn, E. N. (1996). Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. American Journal of Epidemiology, 144(6), 537-547.
58. Lavie CJ, Milan RV, Verma A, Sc O’Keefe JH. (2009). C-reactive protein and cardiovascular diseases-is it ready for primetime?. American Journal of the Medical Sciences, 338(6), 486-492. doi: 10.1097/MAJ.0b013e3181c61b66.
59. Libby, P., Sc Hansson, G. K. (1991). Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Laboratory Investigation, 64(1), 5-15.
60. Libby, P., Sc Theroux, P. (2005). Pathophysiology of coronary artery disease. Circulation, 111(25), 3481-3488. doi: 10.1161/CIRCULATIONAHA. 105.537878.
61. Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., Maseri, A. (1994). The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. The New England Journal of Medicine, 331(J), 417-424. doi: 10.1056/NE JM199408183310701.
62. Llaneza, P., Garcia-Portilla, M. P., Llaneza-Suarez, D., Armott, B., Sc Perez-Lopez, F. R. (2012). Depressive disorders and the menopause transition. Maturitas, 71(2), 120-130. doi: 10.1016/j. maturitas.2011.11.017.
63. Lloyd-Jones, D., Adams, R., Camethon, M., De Simone, G., Ferguson, T. B., Flegal, K. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2009). Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119(3), 480-486. doi: 10.1161/CIRCULATIONAHA. 108.191259.
64. Low, C. A., Thurston, R. C., Sc Matthews, K. A. (2010). Psychosocial factors in the development of heart disease in women: Current research and future directions. Psychosomatic Medicine, 72(9), 842-854. doi: 10.1097/PSY.0b013e318lf6934f.
65. Main, C., Knight, B., Moxham, T., Gabriel Sanchez, R., Sanchez Gomez, L. M., Roque i Figuls, M., Bonfill, C. X. (2013). Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews, (4), CD002229. doi: 10.1002/14651858.CD002229.pub3
66. Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L. Women’s Health Initiative Investigators. (2003). Estrogen plus progestin and the risk of coronary heart disease. The New England Journal of Medicine, 549(6), 523-534. doi:10.1056/NEJMoa030808.
67. Maijoribanks, J., Farquhar, C., Roberts, H., & Lethaby, A. (2012). Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews, (7), CD004143. doi: 10.1002/14651858.CD004143.pub4
68. McSweeney, J. C., Cody, M., O’Sullivan, P., Elberson, K., Moser, D. K., & Garvin, B. J. (2003). Women’s early warning symptoms of acute myocardial infarction. Circulation, 108(21), 2619-2623. doi: 10.1161/01.CIR.0000097116.29625.7C.
69. Miller, G. E., Freedland, K. E., Duntley, S., & Carney, R. M. (2005). Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. The American Journal of Cardiology, 95(3), 317-321. doi:10.1016/j.amjcard.2004.09.026.
70. Mills, P. J., Dimsdale, J. E., Nelesen, R. A., Sc Dillon, E. (1996). Psychologic characteristics asso-ciated with acute stressor-induced leukocyte subset redistribution. Journal of Psychosomatic Research, 40(A), 417-423. pii: 0022399995006141.
71. Moller-Leimkuhler, A. M. (2008). Women with coronary artery disease and depression: A neglected risk group. The World Journal of Biological Psychiatry, 9(2), 92-101. doi: 10.1080/15622970701275281.
72. Mommersteeg, P. M., Pelle, A. J., Ramakers, C., Szabo, B. M., Denollet, J., Sc Kupper, N. (2011). Type D personality and course of health status over 18 months in outpatients with heart failure: Multiple mediating inflammatory biomarkers. Brain, Behavior, and Immunity, 26(2), 301-310. doi: 10.1016/j.bbi.2011.09.010.
73. Monsalve, E., Oviedo, P. J., Garcia-Perez, M. A., Tarin, J. J., Cano, A., Sc Hermenegildo, C. (2007). Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovascular Research, 75(1), 66-72. doi: 10.1016/j. cardiores.2006.09.020.
74. Nicholson, A., Kuper, H., Sc Hemingway, H. (2006). Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. European Heart Journal, 27(23), 2763-2774.
75. Owen, N., Poulton, T., Hay, F. C., Mohamed-Ali, V., Sc Steptoe, A. (2003). Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain, Behavior, and Immunity, 17(4), 286-295. pii: S0889159103000588.
76. Panting, J. R., Gatehouse, P. D., Yang, G. Z., Grothues, F., Firmin, D. N., Collins, P., Pennell, D. J. (2002). Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. The New England Journal of Medicine, 346(25), 1948-1953. doi: 10.1056/NEJMoa012369.
77. Prather, A. A., Epel, E. S., Cohen, B. E., Neylan, T. C., Sc Whooley, M. A. (2013). Gender differ-ences in the prospective associations of self-reported sleep quality with biomarkers of systemic inflammation and coagulation: Findings from the Heart and Soul Study. Journal of Psychiatric Research, 47(9), 1228-1235. doi: 10.1016/j.jpsychires.2013.05.004.
78. Qasim AN, Budharaju, V, Mehta, NN, St Clair C, Farouk S, Braunstein, S, Reilly MP. (2011). Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. ClinicalEndocrinology, 74(1),44-50. doi: 10. Ill 1/j. 1365-2265.2010.03879.x.
79. Ridker, P. M., Buring, J. E., Rifai, N., Sc Cook, N. R. (2007). Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA, the Journal of the American Medical Association, 297(6), 611-619. doi: 10.1001/jama.297.6.611.
80. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., Sc Hennekens, C. H. (1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. The New England Journal of Medicine, 336(14), 973-979. doi: 10.1056/NEJM199704033361401.
81. Roest, A. M., Martens, E. J., Denollet, J., & de Jonge, P. (2010). Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosomatic Medicine, 72(6), 563-569. doi: 10.1097/PS Y.0b013e318 ldbff97.
82. Roger, VL, Farkouh, ME, Weston, SA, Reeder, GS, Jacobsen, SJ, Zinsmeister, AR, Gabriel, S E. (2000). Sex differences in evaluation and outcome of unstable angina. JAMA, the Journal of the American Medical Association, 283(5), 646-652. pii: jcc90003.
83. Ross, R. (1986). The pathogenesis of atherosclerosis-an update. The New England Journal of Medicine, 314(8), 488-500. doi: 10.1056/NEJM 198602203140806.
84. Rudnicka, A. R., Rumley, A., Whincup, P. H., Lowe, G. D., & Strachan, D. P. (2011). Sex differ-ences in the relationship between inflammatory and hemostatic biomarkers and metabolic syndrome: British 1958 Birth Cohort. Journal of Thrombosis and Haemostasis, 9(12), 2337-2344. doi: 10.111 l/j. 1538-7836.2011.04517.
85. Rutledge, T., Reis, S. E., Olson, M., Owens, J., Kelsey, S. F., Pepine, C. J, Merz, C. N. (2006). Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: The NHLBI-sponsored WISE study. Psychosomatic Medicine, 68(2), 217-223. doi: 10.1097/01.psy.0000195751.94998.e3.
86. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., Sc Vale, W. (1987). Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science, 255(4826), 522-524.
87. Sedlak, T. L., Lee, M., Izadnegahdar, M., Merz, C. N., Gao, M., Sc Humphries, K. H. (2013). Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. American Heart Journal, 166(1), 38-44. doi: 10.1016/j.ahj.2013.03.015.
88. Segerstrom, S. C., Sc Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130(A), 601-630. doi: 10.1037/0033-2909.130.4.601.
89. Shanmugasegaram, S., Russell, K. L., Kovacs, A. H., Stewart, D. E., Sc Grace, S. L. (2012). Gender and sex differences in prevalence of major depression in coronary artery disease patients: A meta-analysis. Maturitas, 75(4), 305-311. doi: 10.1016/j.maturitas.2012.09.005.
90. Shaw, J. A., Kingwell, B. A., Walton, A. S., Cameron, J. D., Pillay, P., Gatzka, C. D., Dart, A. M. (2002). Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease. Journal of the American College of Cardiology, 59(10), 1637-1643. pii: S0735109702018429.
91. Soares, C. N. (2013). Depression in periand postmenopausal women: Prevalence, pathophysiology and pharmacological management. Drugs and Aging, 30(9), 677-685. doi: 10.1007/s40266-013-0100-l.
92. Soares, C. N., Almeida, O. P., Joffe, H., Sc Cohen, L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebocontrolled trial. Archives of General Psychiatry, 58(6), 529-534. pii: yoa20238.
93. Suis, J., Sc Bunde, J. (2005). Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin, 131(2), 260-300. doi: 10.1037/0033-2909.131.2.260.
94. Tracey, K. J. (2002). The inflammatory reflex. Nature, 420(6911), 853-859. doi: 10.1038/nature01321.
95. Vaccarino, V., Badimon, L., Corti, R., de Wit, C., Dorobantu, M., Manfrini, O, Bugiardini, R. (2013). Presentation, management, and outcomes of ischaemic heart disease in women. Nature Reviews. Cardiology, 10, 508-518. doi:10.1038/nrcardio.2013.93.
96. van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, J., van Veldhuisen, D. J., van den Berg, M. P. (2004). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomatic Medicine, 66(6), 814-822. doi: 10.1097/0l.psy.0000146294.82810.9c.
97. Wang, H. X., Leineweber, C., Kirkeeide, R., Svane, B., Schenck-Gustafsson, K., Theorell, T., Sc Orth-Gomér, K. (2007). Psychosocial stress and atherosclerosis: Family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study. Journal of Internal Medicine, 261(3), 245-254. doi: 10.1111/j. 1365-2796.2006.01759.x.
98. Weber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. The Journal of Steroid Biochemistry and Molecular Biology, 142, 90-98. doi: 10.1016/j.jsbmb.2013.06.001.
99. WHO. (2008). The global burden of disease: 2004 update (Department of Human Science and Informatics, Trans.). Geneva: World Health Organization.
100. Whooley, M. A., de Jonge, P., Vittinghoff, E., Otte, C., Moos, R., Carney, R. M, Browner, W. S. (2008). Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA, the Journal of the American Medical Association, 300(20), 2379-2388. doi:10.1001/jama.2008.711.
101. Williams, K. E., Marsh, W. K., & Rasgon, N. L. (2007). Mood disorders and fertility in women: A critical review of the literature and implications for future research. Human Reproduction Update, 13(6), 607-616. doi:10.1093/humupd/dmm019.
102. Winkleby, M. A., Jatulis, D. E., Frank, E., Sc Fortmann, S. P. (1992). Socioeconomic status and health: How education, income, and occupation contribute to risk factors for cardiovascular disease. American Journal of Public Health, 82(6), 816-820.
103. Worsley, R., Davis, S. R., Gavrilidis, E., Gibbs, Z., Lee, S., Burger, H., Sc Kulkarni, J. (2012). Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas, 73(2), 127-133. doi:10.1016/j.maturitas.2012.06.011.